Nektar Therapeutics Other Noncash Income (Expense)
Nektar Therapeutics (NKTR) reported Other Noncash Income (Expense) of $7.71 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-11-08
- Nektar Therapeutics other noncash income (expense) for the quarter ending 2024-09-30 was $2.06M, a 48.23% decline year-over-year.
- Nektar Therapeutics other noncash income (expense) for the quarter ending 2024-06-30 was $2.58M, a 48.54% decline year-over-year.
- Nektar Therapeutics other noncash income (expense) for the quarter ending 2024-03-31 was $3.06M, a 2.11% decline year-over-year.
- Nektar Therapeutics other noncash income (expense) for the quarter ending 2023-09-30 was $3.99M, a 271.92% increase year-over-year.
- Nektar Therapeutics other noncash income (expense) for fiscal 2017 was $881.00K, a 59.68% decline from fiscal 2016.
- Nektar Therapeutics other noncash income (expense) for fiscal 2016 was $2.19M, a 7.61% decline from fiscal 2015.
- Nektar Therapeutics other noncash income (expense) for fiscal 2015 was $2.37M, a 322.32% increase from fiscal 2014.
- Nektar Therapeutics other noncash income (expense) for fiscal 2014 was $560.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $4.65M derived: sum of 2 quarters · filed 2024-11-08 | $7.71M 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $5.65M 10-Q · filed 2024-08-09 | ||||||
| 2024-03-31 | $3.06M 10-Q · filed 2024-05-10 | |||||||
| 2023-09-30 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $9.01M derived: sum of 2 quarters · filed 2024-11-08 | $12.14M 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | $5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $8.15M 10-Q · filed 2024-08-09 | ||||||
| 2023-03-31 | $3.13M 10-Q · filed 2024-05-10 | |||||||
| 2022-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.65M derived: sum of 2 quarters · filed 2023-11-08 | $372.00K 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | $576.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$700.00K 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | -$1.28M 10-Q · filed 2023-05-10 | |||||||
| 2021-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$3.33M derived: sum of 2 quarters · filed 2022-11-04 | -$5.68M 10-Q · filed 2022-11-04 | |||||
| 2021-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$4.09M 10-Q · filed 2022-08-05 | ||||||
| 2021-03-31 | -$2.35M 10-Q · filed 2022-05-06 | |||||||
| 2020-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$2.44M derived: sum of 2 quarters · filed 2021-11-05 | -$1.15M 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | -$507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $782.00K 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | $1.29M 10-Q · filed 2021-05-07 | |||||||
| 2019-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.96M derived: sum of 2 quarters · filed 2020-11-06 | $9.15M 10-Q · filed 2020-11-06 | $10.42M 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $6.33M 10-Q · filed 2020-08-07 | $7.83M 10-Q · filed 2019-08-09 | |||||
| 2019-03-31 | $3.18M 10-Q · filed 2020-05-08 | $4.30M 10-Q · filed 2019-05-09 | ||||||
| 2018-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $7.77M derived: sum of 2 quarters · filed 2019-11-07 | $8.14M 10-Q · filed 2019-11-07 | $7.65M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $3.99M 10-Q · filed 2019-08-09 | $3.50M derived: sum of 3 quarters · filed 2019-08-09 | $3.78M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $370.00K 10-Q · filed 2019-05-09 | -$119.00K derived: sum of 2 quarters · filed 2019-05-09 | $162.00K derived: sum of 3 quarters · filed 2019-05-09 | $520.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$208.00K derived: sum of 2 quarters · filed 2018-11-08 | $150.00K derived: sum of 3 quarters · filed 2018-11-08 | $881.00K 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $639.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.37M 10-Q · filed 2018-11-08 | $1.36M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $358.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.09M 10-Q · filed 2018-08-09 | $1.08M derived: sum of 3 quarters · filed 2018-08-09 | $2.01M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $731.00K 10-Q · filed 2018-05-10 | $726.00K derived: sum of 2 quarters · filed 2018-05-10 | $1.66M derived: sum of 3 quarters · filed 2018-05-10 | $2.30M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $925.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.57M derived: sum of 3 quarters · filed 2018-03-01 | $2.19M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $930.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.57M derived: sum of 2 quarters · filed 2017-11-08 | $2.19M 10-Q · filed 2017-11-08 | $3.11M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.26M 10-Q · filed 2017-08-09 | $2.18M derived: sum of 3 quarters · filed 2018-03-01 | $3.00M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $617.00K 10-Q · filed 2017-05-10 | $1.53M derived: sum of 2 quarters · filed 2018-03-01 | $2.36M derived: sum of 3 quarters · filed 2018-03-01 | $2.04M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.74M derived: sum of 2 quarters · filed 2018-03-01 | $1.43M derived: sum of 3 quarters · filed 2018-03-01 | $2.37M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $827.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $510.00K derived: sum of 2 quarters · filed 2016-11-04 | $1.45M 10-Q · filed 2016-11-04 | $2.32M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | -$317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $621.00K 10-Q · filed 2016-08-04 | $1.49M derived: sum of 3 quarters · filed 2017-03-01 | $2.05M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $938.00K 10-Q · filed 2016-05-04 | $1.81M derived: sum of 2 quarters · filed 2017-03-01 | $2.36M derived: sum of 3 quarters · filed 2017-03-01 | $2.27M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.43M derived: sum of 2 quarters · filed 2017-03-01 | $1.34M derived: sum of 3 quarters · filed 2017-03-01 | $560.00K 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $464.00K derived: sum of 2 quarters · filed 2015-11-06 | -$313.00K 10-Q · filed 2015-11-06 | -$645.00K derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$865.00K 10-Q · filed 2015-08-06 | -$1.20M derived: sum of 3 quarters · filed 2016-02-29 | -$1.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$777.00K 10-Q · filed 2015-05-01 | -$1.11M derived: sum of 2 quarters · filed 2016-02-29 | -$1.28M derived: sum of 3 quarters · filed 2016-02-29 | -$1.30M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$505.00K derived: sum of 2 quarters · filed 2016-02-29 | -$525.00K derived: sum of 3 quarters · filed 2016-02-29 | -$664.00K 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$193.00K derived: sum of 2 quarters · filed 2014-11-07 | -$332.00K 10-Q · filed 2014-11-07 | -$2.21M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$159.00K 10-Q · filed 2014-08-01 | -$2.04M derived: sum of 3 quarters · filed 2015-02-26 | -$1.99M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | -$139.00K 10-Q · filed 2014-05-08 | -$2.02M derived: sum of 2 quarters · filed 2015-02-26 | -$1.97M derived: sum of 3 quarters · filed 2015-02-26 | -$2.36M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$1.83M derived: sum of 2 quarters · filed 2015-02-26 | -$2.23M derived: sum of 3 quarters · filed 2015-02-26 | -$2.52M 10-K · filed 2015-02-26 | -$845.00K 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$346.00K derived: sum of 2 quarters · filed 2013-11-07 | -$641.00K 10-Q · filed 2013-11-07 | $641.00K 10-Q · filed 2012-11-09 | -$2.97M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-06-30 | -$393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$688.00K 10-Q · filed 2013-08-09 | -$565.00K 10-Q · filed 2012-08-09 | -$3.01M derived: sum of 3 quarters · filed 2014-02-27 | -$1.43M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | -$295.00K 10-Q · filed 2013-05-09 | -$2.62M derived: sum of 2 quarters · filed 2014-02-27 | -$1.03M derived: sum of 3 quarters · filed 2014-02-27 | -$1.34M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$739.00K derived: sum of 2 quarters · filed 2014-02-27 | -$1.05M derived: sum of 3 quarters · filed 2014-02-27 | -$1.36M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.28M derived: sum of 2 quarters · filed 2012-11-09 | $967.00K 10-Q · filed 2012-11-09 | -$967.00K 10-Q · filed 2011-11-04 | $593.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-06-30 | -$311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$620.00K 10-Q · filed 2012-08-09 | -$994.00K derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2011-03-31 | -$309.00K 10-Q · filed 2012-05-04 | -$683.00K derived: sum of 2 quarters · filed 2013-03-01 | ||||||
| 2010-12-31 | -$374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$198.00K 10-K · filed 2013-03-01 | ||||||
| 2010-09-30 | $176.00K 10-Q · filed 2011-11-04 | |||||||
| 2009-12-31 | $657.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |